Beloxepin

This classification denotes an antidepressant agent with the molecular formula C19H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G905IN29U4, chemically known as ( -)-cis-1,3,4,13b-tetrahydro-2,10-dimethyldibenz(2,3:6,7)oxepino(4,5-c)pyridin-4a(2h)-ol but generally known as beloxepin, which bears US NIH Compound Identifier 166560. European Medicines Agency schedules Beloxepin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05689MIG. The term BELOXEPIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 11997, List 37). BELOXEPIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule beloxepin under HS 29349990 and SITC 51579. As of Q4 2014, BELOXEPIN remains the US FDA Preferred Term for this commodity. Beloxepin bears US NLM identifiers UMLS ID C2698343 and NCI Concept Code C78007. SMILES: OC12C(CN(CC1)C)c1c(Oc3c2cccc3)c(ccc1)C.